The emergence of resistance to multiple antimicrobial agents among enterococci, particularly Enterococcus faecalis and E. faecium, presents an increasingly important problem in the treatment of nosocomial infections (26, 27, 36) . The emergence of glycopeptide resistance in enterococci already resistant to beta-lactams and aminoglycosides is being reported with increasing frequency in the United States and abroad (7, 20) . Among enterococci, four phenotypes of glycopeptide resistance have been reported in the literature: (i) VanA phenotype with high-level resistance to vancomycin (Vm) and teicoplanin (Tei) (1, 19, 42) , (ii) VanB phenotype with resistance to Vm only (1, 34, 41) , (iii) VanC phenotype with noninducible low-level resistance to Vm in E. gallinarum (21, 45) , and (iv) a "VanC-like" phenotype seen in E. casseliflavus but sharing no homology with the vanC gene (21) . The characterization of glycopeptide-resistant enterococci by resistance phenotype only is now complicated by the development of resistance to Tei in an E. faecium strain harboring the vanB gene (15) .
The evolution of the enterococci from innocuous inhabitants of the gastrointestinal tract to a frequent cause of life-threatening nosocomial infections has become more apparent in recent years (40) . In 1992, Wells et al. (47) reported the dissemination of 3-lactamase-producing, aminoglycoside-resistant E. faecalis strains among patients in several wards and services. Although the authors found no evidence of the epidemic strain among personnel, they believed that hand carriage was responsible for transmission of the organism since both patient and environmental samples yielded the organism that caused the epidemic. The possibility of plasmid-mediated dissemination of resistance genes was noted, but when pulsed-field electrophoresis was used to analyze total chromosomal DNAs of multiple isolates, they * Corresponding author. concluded that a single strain of E. faecalis containing the resistance plasmid rather than the intraspecies transmission of the plasmid itself was responsible for the intrahospital spread of the organism. Livomese et al. (22) described a nosocomial outbreak of vancomycin-resistant (Vmr) E. faecium that caused bacteremia and bacteriuria; an electronic thermometer was implicated as the vehicle of transmission. Finally, a cluster of Vmr E. faecium infections was recently reported in a cardiothoracic surgery intensive care unit in New York City in which person-to-person transmission of a single strain was documented (6, 18) .
The goals of our study were to characterize a collection of glycopeptide-resistant human isolates of enterococci from a variety of U.S. hospitals to determine (i) whether there are multiple strains of resistant enterococci within U.S. hospitals, (ii) the utility of various typing techniques for epidemiologic studies, and (iii) the correlation between phenotypic or genotypic methods of characterizing glycopeptide-resistant strains. Antimicrobial susceptibility patterns, plasmid profiles, polymerase chain reaction (PCR) amplification of the vancomycin resistance genes, resistance gene probing, and analysis of genomic restriction digests by pulsed-field gel electrophoresis were used to characterize the isolates. Invitrogen, San Diego, Calif.). The 433-bp vanB and the 796-bp vanC probes were amplified from E. faecalis V583 (38) and the E. gallinarur isolate from hospital AA, respectively. The DNA was labeled with nonradioactive digoxigenin-11-dUTP by using the Genius kit (Boehringer Mannheim), and hybridization was performed under stringent conditions at 65°C overnight (4).
MATERIALS
Plasmid analysis. The first 37 isolates, representing isolates from a variety of hospitals (hospitals A to P) from several states, were selected for strain typing. The plasmid isolation procedure of Weaver and Clewell (46) as modified by Daniel Sahm (37) was used to analyze the isolates. The modifications included growth of the organisms in brain heart infusion broth (Becton Dickinson Microbiology Systems, Cockeysville, Md.) supplemented with 2% glycine and 1 p,g of vancomycin per ml and two RNase digestion steps, the first for 15 to 30 min at 55°C and the second at room temperature.
The remainder of the procedure was described previously (46) . The lysates were electrophoresed in a 0.85% agarose (Ultrapure; Gibco Bethesda Research Laboratories) prepared in 1 x TBE buffer.
The DNA was electroblotted onto a nylon membrane (MagnaGraph; MSI, Westboro, Mass.) in lx TAE buffer (10 mM Tris, 5 mM sodium acetate, 0.5 mM EDTA [pH 7.8]) after pretreatment with 0.2 N NaOH in 0.5 M NaCl, then 4 x TAE, and then lx TAE. The membrane was baked at 80°C for 2 h.
PFGE. The chromosomal DNAs of the first 37 isolates (hospitals A to P) were prepared by lysis in situ in 1% agarose (Ultrapure; GIBCO Bethesda Research Laboratories) blocks by using a modification of the method described by McClelland et al. (24) for pulsed-field gel electrophoresis (PFGE). The pellet from 1 ml of overnight culture was resuspended in 1 ml of ET buffer (100 mM EDTA, 10 mM Tris [pH 8.0]), agarose preheated to 60°C was added, and the mixture was vortexed briefly and poured into molds on ice. The blocks were placed in tubes, treated with ET buffer containing 200 p,g of lysozyme per ml and 0.05% Sarkosyl for 2 h at 30°C, and then incubated overnight at 55°C in ET buffer containing 1 mg of proteinase K per ml and 1% sodium dodecyl sulfate. The blocks were stored at 4°C in ET buffer until needed.
The procedures for SmaI (GIBCO Bethesda Research Laboratories) digestion and electrophoresis in the CHEF-DR II pulsed-field unit (Bio-Rad, Richmond, Calif.) were as described previously (25, 29 Plasmid and PFGE analyses. Of the 37 isolates examined, all had at least one plasmid ranging in size from 1 to 60 kb (Fig. 1) . Most from hospital M had the same pattern, while all of the hospital L isolates had different patterns (data not shown). All of the single isolates from hospitals G, I, J, K, N, 0, and P had unique patterns.
Analysis of the SmaI restriction digests of genomic DNA by PFGE resulted in 21 different patterns among the 37 isolates from 16 hospitals ( Table 3) . Each of the isolates from the eight hospitals (hospitals B, G, I, J, K, N, 0, and P) represented by a single isolate had a unique PFGE pattern; seven of the eight isolates also had a unique plasmid pattern. However, the isolate from hospital B (in New York State) had a plasmid pattern similar to that seen in isolates from hospital A (in New York). In two regions, the same PFGE pattern was shared by isolates from more than one hospital. For example, in New York hospitals, five of seven isolates from hospital A had the same PFGE pattern (pattern A-1) as one of two isolates from hospital C and one of the three isolates from hospital D. One patient in hospital D had three isolates with matching PFGE and plasmid patterns which differed from the patterns seen with isolates from two other patients. All isolates from hospitals L and M, both in Missouri, had the same PFGE pattern. In several cases, we found that when plasmid patterns appeared to be similar, PFGE demonstrated that the isolates were actually different strains, but the reverse was also true, because although the plasmid patterns of some isolates differed, they shared the same PFGE patterns.
Hybridization and PCR gene amplification studies. The collection of 105 isolates was analyzed by PCR by using primers specific for the vanA, vanB, and vanC genes. Sixty-seven of the 70 isolates with the VanA phenotype produced the expected i-kb product with the vanA primers. The remaining three VanA isolates (one from hospital B and two from hospital C) were repeatedly negative in the assay. None of the isolates with the VanB and VanC phenotypes produced positive results with the vanA primers, nor did the three E. casseliflavus isolates. However, the single E. raffinosus isolate, for which the Vm MIC was 16 ,ug/ml and the (27, 39, 43, 44, 48) . The (17) . Although VanC is confined to strains of E. gallinarum, a similar low level of resistance is also observed in isolates of E. casseliflavus (21) . The presence of the vanA gene in E. raffinosus has not been described. This isolate was obtained from a hospital which also had isolates of both E. faecalis and E. faecium which contained the vanA gene and expressed high-level vancomycin resistance. Although the vanA gene was on a plasmid of a size similar to those of plasmids from the other isolates, the E. raffinosus isolate did not demonstrate HLR; therefore, it is considered unclassified. Since we have demonstrated the presence of the vanA gene in the E. raffinosus isolate, the alteration of either the vanR or vanS regulatory genes must be considered in future studies.
Brisson-Noel et al. (5) (8) observed that the existence of genes that are not phenotypically expressed can lead to false-positive hybridization results, but in this case, the weak false-positive hybridization results may be due to an increase in the degree of sequence similarity between the vanB and vanA genes in these isolates (12) .
Plasmid analysis has been used for epidemiologic studies of several outbreaks involving aminoglycoside-resistant and P-lactamase-producing enterococci (23, 32, 35, 49) . However, we have observed that plasmid patterns in enterococci are often unstable; thus, plasmid fingerprinting should not be the sole means of typing these organisms.
In their study of glycopeptide-resistant enterococci isolated in various hospitals in Europe and the United States, Dutka-Malen et al. (9) concluded that the spread of highlevel resistance (VanA phenotype) is due to dissemination of a gene rather than a bacterial clone or a single plasmid. In our study, the vanA gene cluster resided on 34-and 60-kb plasmids, which is in contrast to the 55-kb plasmid in the Spanish isolate (14) .
Several investigators have successfully used PFGE to study the epidemiology of 1-lactamase-producing and aminoglycoside-resistant enterococci (25, 28, 29, 30, 33 Our results and those of others (15, 34) indicate that glycopeptide resistance genotypes do not always correspond to resistance phenotypes determined by antimicrobial susceptibility testing, in that vanA-containing isolates can manifest low-level resistance, as seen in our E. raffinosus isolate, and vanB-containing isolates can express high-level resistance to vancomycin and teicoplanin. Thus, the study of the epidemiology of glycopeptide resistance is perhaps best undertaken by using a combination of phenotypic and genotypic methods rather than phenotypic methods alone.
